Systems Biology of Seasonal Influenza Vaccination in Humans

Here we have used a systems biology approach to study innate and adaptive responses to vaccination against influenza in humans during three consecutive influenza seasons. We studied healthy adults vaccinated with trivalent inactivated influenza vaccine (TIV) or live attenuated influenza vaccine (LAIV). TIV induced higher antibody titers and more plasmablasts than LAIV did. In subjects vaccinated with TIV, early molecular signatures correlated with and could be used to accurately predict later antibody titers in two independent trials. Notably, expression of the kinase CaMKIV at day 3 was inversely correlated with later antibody titers. Vaccination of CaMKIV-deficient mice with TIV induced enhanced antigen-specific antibody titers, which demonstrated an unappreciated role for CaMKIV in the regulation of antibody responses. Thus, systems approaches can be used to predict immunogenicity and provide new mechanistic insights about vaccines.

[1]  E. Hindle,et al.  A YELLOW FEVER VACCINE , 1928, British medical journal.

[2]  C W Potter,et al.  Determinants of immunity to influenza infection in man. , 1979, British medical bulletin.

[3]  P. Wright,et al.  Comparison of long‐term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine , 1985, Journal of medical virology.

[4]  B. Murphy,et al.  Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus , 1986, Journal of clinical microbiology.

[5]  W. Roper,et al.  Prevention and control of influenza: Part I, Vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP). , 1994, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[6]  B. Murphy,et al.  Human immune responses to influenza virus vaccines administered by systemic or mucosal routes. , 1995, Vaccine.

[7]  Y. Hirota,et al.  Antibody efficacy as a keen index to evaluate influenza vaccine effectiveness. , 1997, Vaccine.

[8]  P. Kisielow,et al.  Calmodulin-dependent protein kinase IV during T-cell development. , 1997, Biochemical and biophysical research communications.

[9]  G Shubinsky,et al.  The CD38 lymphocyte differentiation marker: new insight into its ectoenzymatic activity and its role as a signal transducer. , 1997, Immunity.

[10]  A. Means,et al.  Spermiogenesis and exchange of basic nuclear proteins are impaired in male germ cells lacking Camk4 , 2000, Nature Genetics.

[11]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Deaglio,et al.  Human CD38: a (r)evolutionary story of enzymes and receptors. , 2001, Leukemia research.

[13]  A. Means,et al.  Expression of Ca(2+)/calmodulin-dependent protein kinase IV (caMKIV) messenger RNA during murine embryogenesis. , 2001, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[14]  A. Osterhaus,et al.  Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis. , 2002, Vaccine.

[15]  A. Means,et al.  Defective Signaling in a Subpopulation of CD4+ T Cells in the Absence of Ca2+/Calmodulin-Dependent Protein Kinase IV , 2002, Molecular and Cellular Biology.

[16]  K. Rajewsky,et al.  Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1 , 2003, Nature Immunology.

[17]  L. Glimcher,et al.  The X‐box binding protein‐1 transcription factor is required for plasma cell differentiation and the unfolded protein response , 2003, Immunological reviews.

[18]  S. Kato,et al.  Frequencies of dendritic cells (myeloid DC and plasmacytoid DC) and their ratio reduced in pregnant women: comparison with umbilical cord blood and normal healthy adults. , 2003, Human immunology.

[19]  S. Tangye,et al.  BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. , 2003, The Journal of clinical investigation.

[20]  Luis Villarreal,et al.  Cutting Edge: Long-Term B Cell Memory in Humans after Smallpox Vaccination 1 , 2003, The Journal of Immunology.

[21]  J. Trowsdale,et al.  The LILR family: modulators of innate and adaptive immune pathways in health and disease. , 2004, Tissue antigens.

[22]  R. Belshe.  Current status of live attenuated influenza virus vaccine in the US. , 2004, Virus research.

[23]  Uma Sankar,et al.  Calmodulin-dependent Protein Kinase IV Regulates Hematopoietic Stem Cell Maintenance* , 2005, Journal of Biological Chemistry.

[24]  D. Tough,et al.  Cutting Edge: Enhancement of Antibody Responses Through Direct Stimulation of B and T Cells by Type I IFN1 , 2006, The Journal of Immunology.

[25]  Harry B. Greenberg,et al.  Comparison of the Influenza Virus-Specific Effector and Memory B-Cell Responses to Immunization of Children and Adults with Live Attenuated or Inactivated Influenza Virus Vaccines , 2006, Journal of Virology.

[26]  Akira Yamaguchi,et al.  Regulation of osteoclast differentiation and function by the CaMK-CREB pathway , 2006, Nature Medicine.

[27]  A. Takaoka,et al.  Interferon signalling network in innate defence , 2006, Cellular microbiology.

[28]  D. Lewis,et al.  Cellular Immune Responses in Children and Adults Receiving Inactivated or Live Attenuated Influenza Vaccines , 2006, Journal of Virology.

[29]  Bali Pulendran,et al.  Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity , 2006, The Journal of experimental medicine.

[30]  Eva K. Lee.  Large-Scale Optimization-Based Classification Models in Medicine and Biology , 2007, Annals of Biomedical Engineering.

[31]  Cornelia L Dekker,et al.  Humoral and Cellular Immune Responses in Children Given Annual Immunization With Trivalent Inactivated Influenza Vaccine , 2007, The Pediatric infectious disease journal.

[32]  P. Walter,et al.  Signal integration in the endoplasmic reticulum unfolded protein response , 2007, Nature Reviews Molecular Cell Biology.

[33]  Zihai Li,et al.  Endoplasmic reticulum HSP90b1 (gp96, grp94) optimizes B-cell function via chaperoning integrin and TLR but not immunoglobulin. , 2008, Blood.

[34]  Anna Maria Masci,et al.  Calmodulin-dependent kinase IV links Toll-like receptor 4 signaling with survival pathway of activated dendritic cells. , 2008, Blood.

[35]  Bastian R. Angermann,et al.  Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses , 2008, The Journal of experimental medicine.

[36]  Patrick C. Wilson,et al.  Rapid cloning of high-affinity human monoclonal antibodies against influenza virus , 2008, Nature.

[37]  R. K. Evans,et al.  Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin. , 2008, Vaccine.

[38]  Harry B. Greenberg,et al.  Influence of Prior Influenza Vaccination on Antibody and B-Cell Responses , 2008, PloS one.

[39]  S. Fang,et al.  Armet, a UPR-upregulated protein, inhibits cell proliferation and ER stress-induced cell death. , 2008, Experimental cell research.

[40]  Bali Pulendran,et al.  Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology , 2009, Nature Reviews Immunology.

[41]  Eva K. Lee,et al.  Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans , 2009, Nature Immunology.

[42]  A. Barrett,et al.  Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place? , 2009, Current opinion in immunology.

[43]  N. Cox,et al.  Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. , 2009 .

[44]  R. Allen,et al.  Regulation of T‐cell immunity by leucocyte immunoglobulin‐like receptors: innate immune receptors for self on antigen‐presenting cells , 2009, Immunology.

[45]  Mark M. Davis,et al.  Cell type–specific gene expression differences in complex tissues , 2010, Nature Methods.

[46]  Shuzhao Li,et al.  Systems vaccinology: Probing humanity’s diverse immune systems with vaccines , 2014, Proceedings of the National Academy of Sciences.

[47]  J. Treanor,et al.  Safety and immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125) in healthy young adults. , 2010, Vaccine.

[48]  Hong Jin,et al.  Safety, immunogencity, and efficacy of a cold-adapted A/Ann Arbor/6/60 (H2N2) vaccine in mice and ferrets. , 2010, Virology.

[49]  Eva K. Lee,et al.  Analysis of the consistency of a mixed integer programming-based multi-category constrained discriminant model , 2010, Ann. Oper. Res..

[50]  K. Ueki,et al.  The regulatory subunits of PI3K, p85α and p85β, interact with XBP-1 and increase its nuclear translocation , 2010, Nature Medicine.

[51]  Torsten Witte,et al.  Leukocyte Immunoglobulin-Like Receptors as New Players in Autoimmunity , 2010, Clinical reviews in allergy & immunology.

[52]  Uma Kavita,et al.  Immunopotentiation of Trivalent Influenza Vaccine When Given with VAX102, a Recombinant Influenza M2e Vaccine Fused to the TLR5 Ligand Flagellin , 2010, PloS one.

[53]  Gregory A Poland,et al.  Advances in the vaccination of the elderly against influenza: role of a high-dose vaccine , 2010, Expert review of vaccines.

[54]  Bali Pulendran,et al.  Immunological mechanisms of vaccination , 2011, Nature Immunology.